Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[New classification of leukemia].

¹Dep. of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine.

Rinsho Byori. the Japanese Journal of Clinical Pathology

|June 8, 2001

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Morphological diagnoses of the Japan adult leukemia study group acute myeloid leukemia protocols: central review.

International journal of hematology·2001

Same author

Effect of a selective Abl tyrosine kinase inhibitor, STI571, on in vitro growth of BCR-ABL-positive acute lymphoblastic leukemia cells.

Leukemia·2001

Same author

Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki.

Blood·2001

Same author

Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.

Cancer research·2001

Same author

Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells.

Biochemical and biophysical research communications·2001

Same author

ATRA, NF-kappaB and ATL.

Leukemia research·2001

A new World Health Organization (WHO) classification for leukemia integrates genetic data, refining diagnoses for acute myeloid leukemia and myelodysplastic syndromes (MDS). This system enhances diagnostic accuracy and promotes further leukemia research.

Area of Science:

Hematology
Oncology
Cytopathology

Context:

The FAB classification for leukemia diagnosis relies on cytomorphology.
The World Health Organization (WHO) proposed a new classification system.
This system incorporates genetically defined entities of acute leukemia.

Purpose:

To introduce a novel classification system for leukemia.
To update diagnostic criteria for acute myeloid leukemia (AML).
To revise categories within myelodysplastic syndromes (MDS).

Summary:

The WHO classification integrates genetic findings with cytomorphology for leukemia diagnosis.
It establishes four genetically defined acute leukemia entities.
New diagnostic criteria for AML and revised MDS categories are included.

Related Experiment Videos

Impact:

Facilitates more precise leukemia diagnosis.
Enhances understanding of leukemia's genetic basis.
Promotes further research by combining WHO and FAB classifications.